GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aratana Therapeutics Inc (NAS:PETX) » Definitions » Days Inventory

Aratana Therapeutics (Aratana Therapeutics) Days Inventory : 316.19 (As of Mar. 2019)


View and export this data going back to 2013. Start your Free Trial

What is Aratana Therapeutics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Aratana Therapeutics's Average Total Inventories for the three months ended in Mar. 2019 was $11.13 Mil. Aratana Therapeutics's Cost of Goods Sold for the three months ended in Mar. 2019 was $3.21 Mil. Hence, Aratana Therapeutics's Days Inventory for the three months ended in Mar. 2019 was 316.19.

The historical rank and industry rank for Aratana Therapeutics's Days Inventory or its related term are showing as below:

PETX's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 189.69
* Ranked among companies with meaningful Days Inventory only.

Aratana Therapeutics's Days Inventory declined from Mar. 2018 (935.89) to Mar. 2019 (316.19).

Inventory Turnover measures how fast the company turns over its inventory within a year. Aratana Therapeutics's Inventory Turnover for the three months ended in Mar. 2019 was 0.29.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Aratana Therapeutics's Inventory-to-Revenue for the three months ended in Mar. 2019 was 1.51.


Aratana Therapeutics Days Inventory Historical Data

The historical data trend for Aratana Therapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aratana Therapeutics Days Inventory Chart

Aratana Therapeutics Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Days Inventory
Get a 7-Day Free Trial 217.20 704.39 699.41 247.63 428.50

Aratana Therapeutics Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 935.89 599.04 375.17 321.69 316.19

Competitive Comparison of Aratana Therapeutics's Days Inventory

For the Biotechnology subindustry, Aratana Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aratana Therapeutics's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aratana Therapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Aratana Therapeutics's Days Inventory falls into.



Aratana Therapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Aratana Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2018 is calculated as

Days Inventory (A: Dec. 2018 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2017 ) + Total Inventories (A: Dec. 2018 )) / count ) / Cost of Goods Sold (A: Dec. 2018 )*Days in Period
=( (13.576 + 11.425) / 2 ) / 10.648*365
=12.5005 / 10.648*365
=428.50

Aratana Therapeutics's Days Inventory for the quarter that ended in Mar. 2019 is calculated as:

Days Inventory (Q: Mar. 2019 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2018 ) + Total Inventories (Q: Mar. 2019 )) / count ) / Cost of Goods Sold (Q: Mar. 2019 )*Days in Period
=( (11.425 + 10.828) / 2 ) / 3.211*365 / 4
=11.1265 / 3.211*365 / 4
=316.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aratana Therapeutics  (NAS:PETX) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Aratana Therapeutics's Inventory Turnover for the three months ended in Mar. 2019 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Aratana Therapeutics's Inventory to Revenue for the three months ended in Mar. 2019 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Aratana Therapeutics Days Inventory Related Terms

Thank you for viewing the detailed overview of Aratana Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Aratana Therapeutics (Aratana Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
11400 Tomahawk Creek Parkway, Suite 340, Leawood, KS, USA, 66211
Aratana Therapeutics Inc is a pet therapeutics company. Its main activity is the licensing, developing, and commercializing of innovative biopharmaceutical products for companion animals. The company's portfolio consists of therapeutic candidates such as small-molecule pharmaceuticals and large-molecule biologics. The main product candidates in development comprise small-molecule pharmaceuticals directed at treating osteoarthritis pain, inflammation, appetite stimulation, and post-operative pain. The firm's strategy consists of licensing proprietary technology from human biopharmaceutical companies or academia to develop therapeutics specifically for use in pets.
Executives
Roche Robert P Jr director 41 MOORES ROAD FRAZER PA 19355
Vort John Vander director C/O MPM ASSET MANAGEMENT, 200 CLARENDON STREET 54TH FLOOR, BOSTON MA 02116
Lowell W Robinson director 470 WEST END AVENUE, NEW YORK NY 10024
Wendy L Yarno director
David L Brinkley director 901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO CA 94080
Merilee Raines director IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Kevin Kotler 10 percent owner C/O BROADFIN CAPITAL, LLC, 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Broadfin Capital, Llc 10 percent owner 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Broadfin Healthcare Master Fund Ltd 10 percent owner C/O 20 GENESIS CLOSE, ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344, GRAND CAYMAN E9 KY1-1108
Craig A. Barbarosh director 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Hockaday Irvine O Jr director SPRINT NEXTEL CORPORATION, 2001 EDMUND HALLEY DRIVE, RESTON VA 20191
Craig A Tooman director, officer: President and CEO
Peter Steven St director, officer: PRESIDENT AND CEO MPM CAPITAL, 200 CLARENDON STREET 54TH FLOOR, BOSTON MA 02116
Laura Brege director C/O ONYX PHARMACEUTICALS, INC., 2100 POWELL STREET, EMERYVILLE CA 94608
Jay Lichter director C/O ARATANA THERAPEUTICS, INC., 11400 TOMAHAWK CREEK PARKWAY, SUITE 340, LEAWOOD KS 66211